Engineered bacterial vesicles restore the power of last-resort antibiotics (IMAGE)
Caption
Researchers developed extracellular vesicles carrying the bacterial peptide TimP and the antibiotic polymyxin B (PMB), creating a targeted drug delivery platform called PMB@TimP EVs. The vesicles reprogram multidrug-resistant Escherichia coli to become more vulnerable to PMB, allowing the antibiotic to work at lower doses.
Credit
Prof. Kwang-sun Kim from Pusan National University, Republic of Korea
Usage Restrictions
Cannot be reused without permission.
License
Original content